Aravis SA is a private equity firm. Based in Zurich, Switzerland. Known portfolio companies include NovImmune, Bird Rock Bio, MerLion Pharma, Evolva, Bellerophon Therapeutics and Hedera-22, 9 companies in all.
Is Aravis SA a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- FoodHealthcare
- Focus
- BiotechDrug DiscoveryMedTechPharmaSwiss-focusedTherapeutics
Contacts
Aravis SA portfolio companies (9)
- NovImmune
- Bird Rock Bio
- MerLion Pharma
- Evolva
- Bellerophon Therapeutics
- Hedera-22
- Synaffix BV
- Synosia Therapeutics
- Telormedix
Co-investors
Funds that share portfolio companies with Aravis SA.
Similar funds
Showing 20 of 100
About Aravis SA
The firm's listing covers sectors Food and Healthcare, and focus areas Biotech, Drug Discovery, MedTech and Pharma; known deals cluster at Growth, Seed and Series A.
Across the known portfolio, 6 co-investors appear alongside Aravis SA, including Bz Bank, Apposite Capital and Rosetta Capital.
Frequently asked questions
What is Aravis SA?
Aravis SA is a private equity firm based in Zurich, Switzerland, with a known portfolio of 9 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Aravis SA invest in?
Listed sectors include Food and Healthcare; listed focus areas include Biotech, Drug Discovery, MedTech and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Aravis SA invest at?
The known deals of Aravis SA include Growth, Seed and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact Aravis SA?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal